ํŠธ๋ผ๋„ฅ์‚ผ์‚ฐ ์‹œ์žฅ

ID: MRFR/CnM/31710-CR
156 Pages
Rahul Gotadki
Last Updated: June 08, 2026
ํŠธ๋ผ๋„ฅ์‚ผ์‚ฐ ์‹œ์žฅ ์กฐ์‚ฌ ๋ณด๊ณ ์„œ ์ •๋ณด๋Š” ์ œํ˜• ์œ ํ˜•๋ณ„(๊ฒฝ๊ตฌ, ์ฃผ์‚ฌ์ œ, ๊ตญ์†Œ), ์šฉ๋„๋ณ„(์›”๊ฒฝ๊ณผ๋‹ค, ์™ธ๊ณผ์  ์ถœํ˜ˆ ์กฐ์ ˆ, ์™ธ์ƒ ๋ฐ ๋ถ€์ƒ, ์œ ์ „์„ฑ ํ˜ˆ๊ด€๋ถ€์ข…(HAE), ์‚ฐํ›„ ์ถœํ˜ˆ, ๊ธฐํƒ€), ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„(๋ณ‘์› ๋ฐ ์ง„๋ฃŒ์†Œ, ์™ธ๋ž˜ ์ˆ˜์ˆ  ์„ผํ„ฐ, ๊ธฐํƒ€ ๋ฐ ์ง€์—ญ(๋ถ๋ฏธ, ์œ ๋Ÿฝ, ์•„์‹œ์•„ ํƒœํ‰์–‘ ๋ฐ ๊ธฐํƒ€ ๊ตญ๊ฐ€)๋ณ„)์ž…๋‹ˆ๋‹ค. 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Tranexamic Acid Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.22%
2024 Market Size$ 1.01 Billion
2025 Market Size$ 1.07 Billion
2035 Market Size$ 1.77 Billion

Key Players

Bristol-Myers Squibb
Mylan
Teva Pharmaceuticals
Sandoz
Fresenius Kabi
Hikma Pharmaceuticals
Opportunities
  • Surge in Surgical Procedures
  • Regulatory Support and Approvals
  • Advancements in Pharmaceutical Research
  1. 1 ์„น์…˜ I: ์š”์•ฝ ๋ฐ ์ฃผ์š” ํ•˜์ด๋ผ์ดํŠธ
    1. 1.1 ์š”์•ฝ
      1. 1.1.1 ์‹œ์žฅ ๊ฐœ์š”
      2. 1.1.2 ์ฃผ์š” ๊ฒฐ๊ณผ
      3. 1.1.3 ์‹œ์žฅ ์„ธ๋ถ„ํ™”
      4. 1.1.4 ๊ฒฝ์Ÿ ํ™˜๊ฒฝ
      5. 1.1.5 ๋„์ „๊ณผ ๊ธฐํšŒ
      6. 1.1.6 ํ–ฅํ›„ ์ „๋ง
  2. 2 ์„น์…˜ II: ๋ฒ”์œ„ ์ง€์ •, ๋ฐฉ๋ฒ•๋ก  ๋ฐ ์‹œ์žฅ ๊ตฌ์กฐ
    1. 2.1 ์‹œ์žฅ ์†Œ๊ฐœ
      1. 2.1.1 ์ •์˜
      2. 2.1.2 ์—ฐ๊ตฌ ๋ฒ”์œ„
        1. 2.1.2.1 ์—ฐ๊ตฌ ๋ชฉํ‘œ
        2. 2.1.2.2 ๊ฐ€์ •
        3. 2.1.2.3 ์ œํ•œ ์‚ฌํ•ญ
    2. 2.2 ์—ฐ๊ตฌ ๋ฐฉ๋ฒ•๋ก 
      1. 2.2.1 ๊ฐœ์š”
      2. 2.2.2 ๋ฐ์ดํ„ฐ ๋งˆ์ด๋‹
      3. 2.2.3 2์ฐจ ์—ฐ๊ตฌ
      4. 2.2.4 1์ฐจ ์—ฐ๊ตฌ
        1. 2.2.4.1 1์ฐจ ๋ฉด์ ‘ ๋ฐ ์ •๋ณด ์ˆ˜์ง‘ ํ”„๋กœ์„ธ์Šค
        2. 2.2.4.2 ์ฃผ์š” ์‘๋‹ต์ž ๋ถ„์„
      5. 2.2.5 ์˜ˆ์ธก ๋ชจ๋ธ
      6. 2.2.6 ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •
        1. 2.2.6.1 ์ƒํ–ฅ์‹ ์ ‘๊ทผ ๋ฐฉ์‹
        2. 2.2.6.2 ํ•˜ํ–ฅ์‹ ์ ‘๊ทผ ๋ฐฉ์‹
      7. 2.2.7 ๋ฐ์ดํ„ฐ ์‚ผ๊ฐ์ธก๋Ÿ‰
      8. 2.2.8 ๊ฒ€์ฆ
  3. 3 ์„น์…˜ III: ์ •์„ฑ์  ๋ถ„์„
    1. 3.1 ์‹œ์žฅ ์—ญํ•™
      1. 3.1.1 ๊ฐœ์š”
      2. 3.1.2 ๋“œ๋ผ์ด๋ฒ„
      3. 3.1.3 ์ œํ•œ
      4. 3.1.4 ๊ธฐํšŒ
    2. 3.2 ์‹œ์žฅ ์š”์ธ ๋ถ„์„
      1. 3.2.1 ๊ฐ€์น˜ ์‚ฌ์Šฌ ๋ถ„์„
      2. 3.2.2 ํฌํ„ฐ์˜ 5๊ฐ€์ง€ ํž˜ ๋ถ„์„
        1. 3.2.2.1 ๊ณต๊ธ‰์—…์ฒด์˜ ํ˜‘์ƒ๋ ฅ
        2. 3.2.2.2 ๊ตฌ๋งค์ž ๊ต์„ญ๋ ฅ
        3. 3.2.2.3 ์‹ ๊ทœ ์ง„์ž…์ž์˜ ์œ„ํ˜‘
        4. 3.2.2.4 ๋Œ€์ฒด ์œ„ํ˜‘
        5. 3.2.2.5 ๊ฒฝ์Ÿ์˜ ๊ฐ•๋„
      3. 3.2.3 COVID-19 ์˜ํ–ฅ ๋ถ„์„
        1. 3.2.3.1 ์‹œ์žฅ ์˜ํ–ฅ ๋ถ„์„
        2. 3.2.3.2 ์ง€์—ญ ์˜ํ–ฅ
        3. 3.2.3.3 ๊ธฐํšŒ ๋ฐ ์œ„ํ˜‘ ๋ถ„์„
  4. 4 ์„น์…˜ IV: ์ •๋Ÿ‰์  ๋ถ„์„
    1. 4.1 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์ œํ˜• ์œ ํ˜•๋ณ„(USD์‹ญ์–ต)
      1. 4.1.1 ๊ฒฝ๊ตฌ
      2. 4.1.2 ์ฃผ์‚ฌ ๊ฐ€๋Šฅ
      3. 4.1.3 ์ฃผ์ œ
    2. 4.2 ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ, ์šฉ๋„๋ณ„(USD์‹ญ์–ต)
      1. 4.2.1 ์›”๊ฒฝ๊ณผ๋‹ค
      2. 4.2.2 ์ˆ˜์ˆ  ์ถœํ˜ˆ ์ œ์–ด
      3. 4.2.3 ์™ธ์ƒ ๋ฐ ๋ถ€์ƒ
      4. 4.2.4 ์œ ์ „์„ฑ ํ˜ˆ๊ด€๋ถ€์ข…(HAE)
      5. 4.2.5 ์‚ฐํ›„ ์ถœํ˜ˆ
      6. 4.2.6 ๊ธฐํƒ€
    3. 4.3 ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„(USD์‹ญ์–ต)
      1. 4.3.1 ๋ณ‘์› ๋ฐ ์ง„๋ฃŒ์†Œ
      2. 4.3.2 ์™ธ๋ž˜ ์ˆ˜์ˆ  ์„ผํ„ฐ
      3. 4.3.3 ๊ธฐํƒ€
    4. 4.4 ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ, ์ง€์—ญ๋ณ„(USD์‹ญ์–ต)
      1. 4.4.1 ๋ถ๋ฏธ
        1. 4.4.1.1 US
        2. 4.4.1.2 ์บ๋‚˜๋‹ค
      2. 4.4.2 ์œ ๋Ÿฝ
        1. 4.4.2.1 ๋…์ผ
        2. 4.4.2.2 UK
        3. 4.4.2.3 ํ”„๋ž‘์Šค
        4. 4.4.2.4 ๋Ÿฌ์‹œ์•„
        5. 4.4.2.5 ์ดํƒˆ๋ฆฌ์•„
        6. 4.4.2.6 ์ŠคํŽ˜์ธ
        7. 4.4.2.7 ์œ ๋Ÿฝ ๋‚˜๋จธ์ง€ ์ง€์—ญ
      3. 4.4.3 APAC
        1. 4.4.3.1 ์ค‘๊ตญ
        2. 4.4.3.2 ์ธ๋„
        3. 4.4.3.3 ์ผ๋ณธ
        4. 4.4.3.4 ์‚ฌ์šฐ์Šค ํ•œ๊ตญ
        5. 4.4.3.5 ๋ง๋ ˆ์ด์‹œ์•„
        6. 4.4.3.6 ํƒœ๊ตญ
        7. 4.4.3.7 ์ธ๋„๋„ค์‹œ์•„
        8. 4.4.3.8 APAC์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
      4. 4.4.4 ๋‚จ๋ฏธ
        1. 4.4.4.1 ๋ธŒ๋ผ์งˆ
        2. 4.4.4.2 ๋ฉ•์‹œ์ฝ”
        3. 4.4.4.3 ์•„๋ฅดํ—จํ‹ฐ๋‚˜
        4. 4.4.4.4 ๋‚จ์•„๋ฉ”๋ฆฌ์นด์˜ ๋‚˜๋จธ์ง€ ์ง€์—ญ
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC ๊ตญ๊ฐ€
        2. 4.4.5.2 ๋‚จ์•„ํ”„๋ฆฌ์นด
        3. 4.4.5.3 MEA์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
  5. 5 ์„น์…˜ V: ๊ฒฝ์Ÿ ๋ถ„์„
    1. 5.1 ๊ฒฝ์Ÿ ํ™˜๊ฒฝ
      1. 5.1.1 ๊ฐœ์š”
      2. 5.1.2 ๊ฒฝ์Ÿ ๋ถ„์„
      3. 5.1.3 ์‹œ์žฅ ์ ์œ ์œจ ๋ถ„์„
      4. 5.1.4 ์ฃผ์š” ์„ฑ์žฅ์ „๋žต ํ™”ํ•™์†Œ์žฌ
      5. 5.1.5 ๊ฒฝ์Ÿ ๋ฒค์น˜๋งˆํ‚น
      6. 5.1.6 ์ฃผ์š” ํ”Œ๋ ˆ์ด์–ด ๊ฐœ๋ฐœ ํšŸ์ˆ˜ ์กฐ๊ฑด ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ
      7. 5.1.7 ์ฃผ์š” ๊ฐœ๋ฐœ ๋ฐ ์„ฑ์žฅ ์ „๋žต
        1. 5.1.7.1 ์‹ ์ œํ’ˆ ์ถœ์‹œ/์„œ๋น„์Šค ๋ฐฐํฌ
        2. 5.1.7.2 ํ•ฉ๋ณ‘ & ์ธ์ˆ˜
        3. 5.1.7.3 ํ•ฉ์ž‘ ํˆฌ์ž
      8. 5.1.8 ์ฃผ์š” ํ”Œ๋ ˆ์ด์–ด ๊ธˆ์œต ๋งคํŠธ๋ฆญ์Šค
        1. 5.1.8.1 ๋งค์ถœ ๋ฐ ์˜์—…์ด์ต
        2. 5.1.8.2 ์ฃผ์š” ํ”Œ๋ ˆ์ด์–ด R&D ์ง€์ถœ. 2023
    2. 5.2 ํšŒ์‚ฌ ํ”„๋กœํ•„
      1. 5.2.1 ๋ธŒ๋ฆฌ์Šคํ†จ ๋งˆ์ด์–ด์Šค ์Šคํ€ด๋ธŒ (US)
        1. 5.2.1.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.1.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.1.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.1.4 SWOT ๋ถ„์„
        5. 5.2.1.5 ์ฃผ์š” ์ „๋žต
      2. 5.2.2 ๋งˆ์ผ๋ž€ (US)
        1. 5.2.2.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.2.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.2.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.2.4 SWOT ๋ถ„์„
        5. 5.2.2.5 ์ฃผ์š” ์ „๋žต
      3. 5.2.3 Teva Pharmaceuticals (IL)
        1. 5.2.3.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.3.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.3.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.3.4 SWOT ๋ถ„์„
        5. 5.2.3.5 ์ฃผ์š” ์ „๋žต
      4. 5.2.4 ์‚ฐ๋„์Šค (DE)
        1. 5.2.4.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.4.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.4.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.4.4 SWOT ๋ถ„์„
        5. 5.2.4.5 ์ฃผ์š” ์ „๋žต
      5. 5.2.5 ํ”„๋ ˆ์ œ๋‹ˆ์šฐ์Šค ์นด๋น„ (DE)
        1. 5.2.5.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.5.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.5.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.5.4 SWOT ๋ถ„์„
        5. 5.2.5.5 ์ฃผ์š” ์ „๋žต
      6. 5.2.6 Hikma Pharmaceuticals (GB)
        1. 5.2.6.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.6.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.6.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.6.4 SWOT ๋ถ„์„
        5. 5.2.6.5 ์ฃผ์š” ์ „๋žต
      7. 5.2.7 ์•”์   (US)
        1. 5.2.7.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.7.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.7.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.7.4 SWOT ๋ถ„์„
        5. 5.2.7.5 ์ฃผ์š” ์ „๋žต
      8. 5.2.8 ํ™”์ด์ž (US)
        1. 5.2.8.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.8.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.8.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.8.4 SWOT ๋ถ„์„
        5. 5.2.8.5 ์ฃผ์š” ์ „๋žต
      9. 5.2.9 AstraZeneca (GB)
        1. 5.2.9.1 ์žฌ๋ฌด ๊ฐœ์š”
        2. 5.2.9.2 ์ œ๊ณต๋˜๋Š” ์ œํ’ˆ
        3. 5.2.9.3 ์ฃผ์š” ๊ฐœ๋ฐœ
        4. 5.2.9.4 SWOT ๋ถ„์„
        5. 5.2.9.5 ์ฃผ์š” ์ „๋žต
    3. 5.3 ๋ถ€๋ก
      1. 5.3.1 ์ฐธ๊ณ ์ž๋ฃŒ
      2. 5.3.2 ๊ด€๋ จ ๋ณด๊ณ ์„œ
  6. 6 ๊ทธ๋ฆผ ๋ชฉ๋ก
    1. 6.1 ์‹œ์žฅ ๊ฐœ์š”
    2. 6.2 ๋ถ๋ฏธ ์‹œ์žฅ ๋ถ„์„
    3. 6.3 US ์ œํ˜• ์œ ํ˜•๋ณ„ ์‹œ์žฅ ๋ถ„์„
  7. Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ 6.4 US ์‹œ์žฅ ๋ถ„์„
  8. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.5 US ์‹œ์žฅ ๋ถ„์„
    1. 6.6 ์ œ์ œ ์œ ํ˜•๋ณ„ ์บ๋‚˜๋‹ค ์‹œ์žฅ ๋ถ„์„
    2. 6.7 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์บ๋‚˜๋‹ค ์‹œ์žฅ ๋ถ„์„
  9. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.8 ์บ๋‚˜๋‹ค ์‹œ์žฅ ๋ถ„์„
    1. 6.9 ์œ ๋Ÿฝ ์‹œ์žฅ ๋ถ„์„
    2. 6.10 ์ œ์ œ ์œ ํ˜•๋ณ„ ๋…์ผ ์‹œ์žฅ ๋ถ„์„
    3. 6.11 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ ๋…์ผ ์‹œ์žฅ ๋ถ„์„
  10. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.12 ๋…์ผ ์‹œ์žฅ ๋ถ„์„
    1. 6.13 UK ์ œ์ œ ์œ ํ˜•๋ณ„ ์‹œ์žฅ ๋ถ„์„
  11. Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ 6.14 UK ์‹œ์žฅ ๋ถ„์„
  12. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.15 UK ์‹œ์žฅ ๋ถ„์„
    1. 6.16 ์ œ์ œ ์œ ํ˜•๋ณ„ ํ”„๋ž‘์Šค ์‹œ์žฅ ๋ถ„์„
    2. 6.17 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ํ”„๋ž‘์Šค ์‹œ์žฅ ๋ถ„์„
    3. 6.18 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ํ”„๋ž‘์Šค ์‹œ์žฅ ๋ถ„์„
    4. 6.19 ์ œํ˜• ์œ ํ˜•๋ณ„ ๋Ÿฌ์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
  13. Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ 6.20 ๋Ÿฌ์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
  14. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.21 ๋Ÿฌ์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
    1. 6.22 ์ œ์ œ ์œ ํ˜•๋ณ„ ์ดํƒˆ๋ฆฌ์•„ ์‹œ์žฅ ๋ถ„์„
    2. 6.23 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์ดํƒˆ๋ฆฌ์•„ ์‹œ์žฅ ๋ถ„์„
  15. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.24 ์ดํƒˆ๋ฆฌ์•„ ์‹œ์žฅ ๋ถ„์„
    1. 6.25 ์ œ์ œ ์œ ํ˜•๋ณ„ ์ŠคํŽ˜์ธ ์‹œ์žฅ ๋ถ„์„
    2. 6.26 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์ŠคํŽ˜์ธ ์‹œ์žฅ ๋ถ„์„
  16. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.27 ์ŠคํŽ˜์ธ ์‹œ์žฅ ๋ถ„์„
    1. 6.28 ์ œ์ œ ์œ ํ˜•๋ณ„ ๋‚˜๋จธ์ง€ ์œ ๋Ÿฝ ์‹œ์žฅ ๋ถ„์„
    2. 6.29 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์œ ๋Ÿฝ ๋‚˜๋จธ์ง€ ์‹œ์žฅ ๋ถ„์„
    3. 6.30 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ์œ ๋Ÿฝ ๋‚˜๋จธ์ง€ ์‹œ์žฅ ๋ถ„์„
    4. 6.31 APAC ์‹œ์žฅ ๋ถ„์„
    5. 6.32 ์ œ์ œ ์œ ํ˜•๋ณ„ ์ค‘๊ตญ ์‹œ์žฅ ๋ถ„์„
    6. 6.33 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ ์ค‘๊ตญ ์‹œ์žฅ ๋ถ„์„
  17. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.34 ์ค‘๊ตญ ์‹œ์žฅ ๋ถ„์„
    1. 6.35 ์ œํ˜• ์œ ํ˜•๋ณ„ ์ธ๋„ ์‹œ์žฅ ๋ถ„์„
    2. 6.36 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์ธ๋„ ์‹œ์žฅ ๋ถ„์„
  18. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.37 ์ธ๋„ ์‹œ์žฅ ๋ถ„์„
    1. 6.38 ์ œํ˜• ์œ ํ˜•๋ณ„ ์ผ๋ณธ ์‹œ์žฅ ๋ถ„์„
    2. 6.39 ์ผ๋ณธ ์‹œ์žฅ ๋ถ„์„ ์‹ ์ฒญ
  19. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.40 ์ผ๋ณธ ์‹œ์žฅ ๋ถ„์„
    1. 6.41 ์ œํ˜• ์œ ํ˜•๋ณ„ ํ•œ๊ตญ ์‹œ์žฅ ๋ถ„์„
    2. 6.42 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ ํ•œ๊ตญ ์‹œ์žฅ ๋ถ„์„
    3. 6.43 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ํ•œ๊ตญ ์‹œ์žฅ ๋ถ„์„
    4. 6.44 ์ œํ˜• ์œ ํ˜•๋ณ„ ๋ง๋ ˆ์ด์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
  20. Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ 6.45 ๋ง๋ ˆ์ด์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
  21. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.46 ๋ง๋ ˆ์ด์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
    1. 6.47 ์ œ์ œ ์œ ํ˜•๋ณ„ ํƒœ๊ตญ ์‹œ์žฅ ๋ถ„์„
    2. 6.48 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ํƒœ๊ตญ ์‹œ์žฅ ๋ถ„์„
  22. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.49 ํƒœ๊ตญ ์‹œ์žฅ ๋ถ„์„
    1. 6.50 ์ œํ˜• ์œ ํ˜•๋ณ„ ์ธ๋„๋„ค์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
    2. 6.51 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์ธ๋„๋„ค์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
  23. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.52 ์ธ๋„๋„ค์‹œ์•„ ์‹œ์žฅ ๋ถ„์„
    1. 6.53 ๊ณต์‹ ์œ ํ˜•๋ณ„ APAC ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    2. 6.54 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ APAC ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
  24. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.55 APAC ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    1. 6.56 ๋‚จ๋ฏธ ์‹œ์žฅ ๋ถ„์„
    2. 6.57 ์ œํ˜• ์œ ํ˜•๋ณ„ ๋ธŒ๋ผ์งˆ ์‹œ์žฅ ๋ถ„์„
    3. 6.58 ๋ธŒ๋ผ์งˆ ์‹œ์žฅ Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ๋ถ„์„
  25. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.59 ๋ธŒ๋ผ์งˆ ์‹œ์žฅ ๋ถ„์„
    1. 6.60 ์ œ์ œ ์œ ํ˜•๋ณ„ ๋ฉ•์‹œ์ฝ” ์‹œ์žฅ ๋ถ„์„
    2. 6.61 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„ ๋ฉ•์‹œ์ฝ” ์‹œ์žฅ ๋ถ„์„
  26. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.62 ๋ฉ•์‹œ์ฝ” ์‹œ์žฅ ๋ถ„์„
    1. 6.63 ์ œ์ œ ์œ ํ˜•๋ณ„ ์•„๋ฅดํ—จํ‹ฐ๋‚˜ ์‹œ์žฅ ๋ถ„์„
    2. 6.64 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ์•„๋ฅดํ—จํ‹ฐ๋‚˜ ์‹œ์žฅ ๋ถ„์„
  27. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.65 ์•„๋ฅดํ—จํ‹ฐ๋‚˜ ์‹œ์žฅ ๋ถ„์„
    1. 6.66 ์ œ์ œ ์œ ํ˜•๋ณ„ ๋‚จ๋ฏธ ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    2. 6.67 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ๋‚จ์•„๋ฉ”๋ฆฌ์นด ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    3. 6.68 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ๋‚จ๋ฏธ ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    4. 6.69 MEA ์‹œ์žฅ ๋ถ„์„
    5. 6.70 ์ œ์ œ ์œ ํ˜•๋ณ„ GCC ๊ตญ๊ฐ€ ์‹œ์žฅ ๋ถ„์„
    6. 6.71 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ GCC ๊ตญ๊ฐ€ ์‹œ์žฅ ๋ถ„์„
  28. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.72 GCC ๊ตญ๊ฐ€ ์‹œ์žฅ ๋ถ„์„
    1. 6.73 ์ œ์ œ ์œ ํ˜•๋ณ„ ๋‚จ์•„ํ”„๋ฆฌ์นด ์‹œ์žฅ ๋ถ„์„
    2. 6.74 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ ๋‚จ์•„ํ”„๋ฆฌ์นด ์‹œ์žฅ ๋ถ„์„
  29. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.75 ๋‚จ์•„ํ”„๋ฆฌ์นด ์‹œ์žฅ ๋ถ„์„
    1. 6.76 ๋‚˜๋จธ์ง€ MEA ์‹œ์žฅ ์ œํ˜• ์œ ํ˜•๋ณ„ ๋ถ„์„
    2. 6.77 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„ MEA ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
  30. ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 6.78 MEA ์‹œ์žฅ ๋ถ„์„์˜ ๋‚˜๋จธ์ง€ ๋ถ€๋ถ„
    1. 6.79 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ์˜ ์ฃผ์š” ๊ตฌ๋งค ๊ธฐ์ค€
  31. MRFR์˜ 6.80 ์—ฐ๊ตฌ ๊ณผ์ •
    1. 6.81 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ์˜ DRO ๋ถ„์„
    2. 6.82 ๋“œ๋ผ์ด๋ฒ„ ์˜ํ–ฅ ๋ถ„์„: ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ
    3. 6.83 ์ œํ•œ ์˜ํ–ฅ ๋ถ„์„: ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ
    4. 6.84 ๊ณต๊ธ‰/๊ฐ€์น˜ ์‚ฌ์Šฌ: ํ™”ํ•™๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ
    5. 6.85 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์ œ์ œ ์œ ํ˜•๋ณ„, 2024 (% ์ ์œ ์œจ)
    6. 6.86 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์ œ์ œ ์œ ํ˜•๋ณ„, 2024 ~ 2035 (USD Billion)
    7. 6.87 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์šฉ๋„๋ณ„, 2024 (% ์ ์œ ์œจ)
    8. 6.88 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2024 ~ 2035 (USD Billion)
    9. 6.89 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, 2024(% ๊ณต์œ )
    10. 6.90 ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2024 ~ 2035 (USD Billion)
    11. 6.91 ์ฃผ์š” ๊ฒฝ์Ÿ์‚ฌ ๋ฒค์น˜๋งˆํ‚น
  32. 7 ํ…Œ์ด๋ธ” ๋ชฉ๋ก
    1. 7.1 ๊ฐ€์ • ๋ชฉ๋ก
      1. 7.1.1 | 7.2 ๋ถ๋ฏธ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      2. 7.2.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      3. 7.2.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      4. 7.2.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    2. 7.3 US ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.3.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.3.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.3.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    3. 7.4 ์บ๋‚˜๋‹ค ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.4.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.4.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.4.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    4. 7.5 ์œ ๋Ÿฝ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.5.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.5.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.5.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    5. 7.6 ๋…์ผ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.6.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.6.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.6.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    6. 7.7 UK ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.7.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.7.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.7.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    7. 7.8 ํ”„๋ž‘์Šค ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.8.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.8.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.8.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    8. 7.9 ๋Ÿฌ์‹œ์•„ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.9.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.9.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.9.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    9. 7.10 ์ดํƒˆ๋ฆฌ์•„ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.10.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.10.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.10.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    10. 7.11 ์ŠคํŽ˜์ธ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.11.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.11.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.11.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    11. 7.12 ์œ ๋Ÿฝ ๋‚˜๋จธ์ง€ ์ง€์—ญ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.12.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.12.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.12.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    12. 7.13 APAC ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.13.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.13.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.13.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    13. 7.14 ์ค‘๊ตญ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.14.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.14.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.14.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    14. 7.15 ์ธ๋„ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.15.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.15.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.15.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    15. 7.16 ์ผ๋ณธ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.16.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.16.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.16.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    16. 7.17 ํ•œ๊ตญ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.17.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.17.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.17.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    17. 7.18 ๋ง๋ ˆ์ด์‹œ์•„ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.18.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.18.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.18.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    18. 7.19 ํƒœ๊ตญ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.19.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.19.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.19.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    19. 7.20 ์ธ๋„๋„ค์‹œ์•„ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.20.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.20.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.20.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    20. 7.21 APAC์˜ ๋‚˜๋จธ์ง€ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •์น˜; ์˜ˆ์ธก
      1. 7.21.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.21.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.21.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    21. 7.22 ๋‚จ๋ฏธ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.22.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.22.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.22.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    22. 7.23 ๋ธŒ๋ผ์งˆ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.23.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.23.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.23.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    23. 7.24 ๋ฉ•์‹œ์ฝ” ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.24.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.24.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.24.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    24. 7.25 ์•„๋ฅดํ—จํ‹ฐ๋‚˜ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.25.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.25.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.25.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    25. 7.26 ๋‚จ๋ฏธ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •์น˜; ์˜ˆ์ธก
      1. 7.26.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.26.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.26.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    26. 7.27 MEA ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.27.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.27.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.27.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    27. 7.28 GCC ๊ตญ๊ฐ€ ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.28.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.28.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.28.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    28. 7.29 ๋‚จ์•„ํ”„๋ฆฌ์นด ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.29.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.29.2 Apple๋ฆฌ์ผ€์ด์…˜ ๋ณ„, 2025-2035 (USD ์‹ญ์–ต)
      3. 7.29.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    29. 7.30 ๋‚˜๋จธ์ง€ MEA ์‹œ์žฅ ๊ทœ๋ชจ ์ถ”์ •; ์˜ˆ์ธก
      1. 7.30.1 ์ œ์ œ ์œ ํ˜•๋ณ„, 2025-2035 (USD 10์–ต)
      2. 7.30.2 Apple๋ฆฌ์ผ€์ด์…˜๋ณ„, 2025-2035 (USD์‹ญ์–ต)
      3. 7.30.3 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2025-2035 (USD 10์–ต)
    30. 7.31 ์ œํ’ˆ ์ถœ์‹œ/์ œํ’ˆ ๊ฐœ๋ฐœ/์Šน์ธ
      1. 7.31.1 | 7.32 ์ธ์ˆ˜/ํŒŒํŠธ๋„ˆ์‹ญ
      2. 7.32.1 |

ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ ์‹œ์žฅ ์„ธ๋ถ„ํ™”

์ œ์ œ ์œ ํ˜•๋ณ„ ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ(USD์‹ญ์–ต, 2025-2035)

  • ๊ฒฝ๊ตฌ
  • ์ฃผ์‚ฌ ๊ฐ€๋Šฅ
  • ๋‰ด์Šค ์˜ํ™”

์šฉ๋„๋ณ„ ํ™”ํ•™ ๋ฐ ์žฌ๋ฃŒ (USD Billion, 2025-2035)

  • ์›”๊ฒฝ๊ณผ๋‹ค
  • ์™ธ๊ณผ์  ์ถœํ˜ˆ ์กฐ์ ˆ
  • ์™ธ์ƒ ๋ฐ ๋ถ€์ƒ
  • ์œ ์ „์„ฑ ํ˜ˆ๊ด€๋ถ€์ข…(HAE)
  • ์‚ฐํ›„ ์ถœํ˜ˆ
  • ๊ธฐํƒ€

์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ํ™”ํ•™ ๋ฌผ์งˆ ๋ฐ ์žฌ๋ฃŒ(USD์‹ญ์–ต, 2025-2035)

  • ๋ณ‘์› ๋ฐ ์ง„๋ฃŒ์†Œ
  • ์™ธ๋ž˜ ์ˆ˜์ˆ  ์„ผํ„ฐ
  • ๊ธฐํƒ€
Case Study Cover Image
์‚ฌ๋ก€ ์—ฐ๊ตฌ

Aerospace & Defense